Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.25
Delayed Data
As of Sep 23
 +0.08 / +1.55%
Today’s Change
2.80
Today|||52-Week Range
7.80
+3.96%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close5.17
Today’s open5.19
Day’s range5.07 - 5.30
Volume1,439,538
Average volume (3 months)1,618,815
Market cap$555.9M
Dividend yield--
Data as of 09/23/2016

Growth & Valuation

Earnings growth (last year)+3.25%
Earnings growth (this year)-2.96%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+26.37%
P/E ratioNM
Price/Sales38.35
Price/Book6.35

Competitors

 Today’s
change
Today’s
% change
FLMLFlamel Technologies ...+0.01+0.07%
CTMXCytomX Therapeutics ...-1.02-6.12%
OTICOtonomy Inc-0.74-4.02%
ACRSAclaris Therapeutics...-0.17-0.68%
Data as of 09/23/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$13.7M
Annual profit (last year)-$123.1M
Net profit margin-900.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
Boston, Massachusetts

Forecasts

Search for Jobs